Evidence map›Paper›PMID 39754278›Full record

ArticleThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2025

Patient preferences for empiric TB treatment initiation.

J Sung, M Musoke, Y Baik, A Twinamasiko, M Lamunu, V Nabacwa, A Sanyu, A Kityamuwesi, A Katamba, D W Dowdy

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

J SungJohns Hopkins University School of Medicine, Division of Infectious Diseases, Baltimore, MD, USA;, Uganda Tuberculosis Implementation Research Consortium, Walimu, Kampala, Uganda.
M MusokeUganda Tuberculosis Implementation Research Consortium, Walimu, Kampala, Uganda.
Y BaikUganda Tuberculosis Implementation Research Consortium, Walimu, Kampala, Uganda;, Johns Hopkins Bloomberg School of Public Health, Department of International Health, Baltimore, MD, USA.
A TwinamasikoUganda Tuberculosis Implementation Research Consortium, Walimu, Kampala, Uganda.
M LamunuUganda Tuberculosis Implementation Research Consortium, Walimu, Kampala, Uganda.
V NabacwaUganda Tuberculosis Implementation Research Consortium, Walimu, Kampala, Uganda.
A SanyuUganda Tuberculosis Implementation Research Consortium, Walimu, Kampala, Uganda.
A KityamuwesiUganda Tuberculosis Implementation Research Consortium, Walimu, Kampala, Uganda.
A KatambaUganda Tuberculosis Implementation Research Consortium, Walimu, Kampala, Uganda;, Clinical Epidemiology and Biostatistics Unit, Department of Internal Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
D W DowdyUganda Tuberculosis Implementation Research Consortium, Walimu, Kampala, Uganda;, Johns Hopkins Bloomberg School of Public Health, Department of Epidemiology, Baltimore, MD, USA.

Funding

RESEARCH TRAINING IN MICROBIAL DISEASEST32AI007291 · NIAID · JOHNS HOPKINS UNIVERSITY · PI JOEL N BLANKSON, Sara Elizabeth Cosgrove · 1986 to 2026
$9.1M
Optimizing Implementation of Digital X-ray with Computer-Aided Detection for Community-Based Tuberculosis ScreeningK23AI185268 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Joowhan Sung · 2024 to 2026
$591k
An implementation science approach to the design and evaluation of tuberculosis self-testing in PeruK01HL165095 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI Yeon Soo Baik · 2023 to 2026
$576k
PredicTB: Validating a clinical risk score for early management of tuberculosis in Ugandan primary health clinicsR21AI161301 · NIAID · JOHNS HOPKINS UNIVERSITY · PI DOWDY, DAVID WESLEY · 2021 to 2022
$379k
NHLBI NIH HHS K01 HL165095NIAID NIH HHS K23 AI185268NIAID NIH HHS R21 AI161301NIAID NIH HHS T32 AI007291
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39754278
PMCPMC11924582

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.